The Lancet Respiratory Medicine, April 2020, Volume 8, Issue 4, Pages 321-422, e14-e26
Explore the current issue of The Lancet Respiratory Medicine, a monthly journal covering content in respiratory medicine and critical care
Explore the current issue of The Lancet Respiratory Medicine, a monthly journal covering content in respiratory medicine and critical care
Later this month, Indians will head to the polls in what will be the largest election in history. 970 million people, more than 10% of…
Dengue fever is a viral infection caused by the dengue virus, which contributes to tens of thousands of deaths annually. Endemic to tropical and subtropical…
Cabozantinib shows promising activity in patients with MPPGs.
Launched as a public–private partnership funded by the Foundation for the National Institutes of Health, the Study to Advance Bone Mineral Density as a Regulatory…
Nivolumab monotherapy and nivolumab plus ipilimumab combination therapy showed promise in the CheckMate 358 study as potential treatment options for recurrent or metastatic cervical cancer.…
A 47-year-old woman came to our institution with a 1-month history of breast erythema, swelling, and a new 1 cm purple skin plaque on her…
Total national health expenditure is associated with geographical inequalities in lymphoid malignancy prognosis. Policy decisions on allocating economic resources and implementing evidence-based models of care…
The addition of anlotinib to neoadjuvant chemotherapy showed manageable toxicity and encouraging antitumor activity for patients with clinical stage II/III TNBC.
Universal health coverage (UHC) means, according to WHO’s definition, that “all people have access to the full range of quality health services they need, when…
Despite great treatment advances in multiple myeloma, relapses are frequent and the disease remains a considerable source of morbidity and mortality.1 As treatments advance and…